These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28017774)

  • 1. Identification of esterase involved in the metabolism of two corticosteroid soft drugs.
    Samir A; Bodor N; Imai T
    Biochem Pharmacol; 2017 Mar; 127():82-89. PubMed ID: 28017774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of simultaneous quantification method of loteprednol etabonate (LE) and its acidic metabolites, and analysis of LE metabolism in rat.
    Samir A; Kage A; Ohura K; Imai T
    Xenobiotica; 2019 May; 49(5):569-576. PubMed ID: 29781759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent analogues of etiprednol dicloacetate, a second generation of soft corticosteroids.
    Bodor N; Zubovics Z; Kurucz I; Sólyom S; Bodor E
    J Pharm Pharmacol; 2017 Dec; 69(12):1745-1753. PubMed ID: 28980320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
    Wu WM; Tang Y; Buchwald P; Bodor N
    Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft drugs. 19. Pharmacokinetics, metabolism and excretion of a novel soft corticosteroid, loteprednol etabonate, in rats.
    Bodor N; Wu WM; Murakami T; Engel S
    Pharm Res; 1995 Jun; 12(6):875-9. PubMed ID: 7667193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to detect systemic levels, and effects of loteprednol etabonate and its metabolite, PJ-91, following chronic ocular administration.
    Howes J; Novack GD
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):153-8. PubMed ID: 9572541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes.
    Druzgala P; Wu WM; Bodor N
    Curr Eye Res; 1991 Oct; 10(10):933-7. PubMed ID: 1959381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166).
    Kurucz I; Tóth S; Németh K; Török K; Csillik-Perczel V; Pataki A; Salamon C; Nagy Z; Székely JI; Horváth K; Bodor N
    J Pharmacol Exp Ther; 2003 Oct; 307(1):83-92. PubMed ID: 12893841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft drugs. 18. Oral and rectal delivery of loteprednol etabonate, a novel soft corticosteroid, in rats--for safer treatment of gastrointestinal inflammation.
    Bodor N; Murakami T; Wu WM
    Pharm Res; 1995 Jun; 12(6):869-74. PubMed ID: 7667192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate.
    Bodor N; Loftsson T; Wu WM
    Pharm Res; 1992 Oct; 9(10):1275-8. PubMed ID: 1448425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate.
    Druzgala P; Hochhaus G; Bodor N
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):149-54. PubMed ID: 2004037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of delta1-cortienic acid on skin blanching, pharmacokinetics and stability of loteprednol etabonate.
    Wu WM; Bodor ET; Howes J; Bodor N
    Pharmazie; 2012 May; 67(5):406-10. PubMed ID: 22764572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.
    Abelson M; Howes J; George M
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):533-42. PubMed ID: 9867336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
    Glogowski S; Lowe E; Siou-Mermet R; Ong T; Richardson M
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):66-73. PubMed ID: 24325539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid.
    Comstock TL; Sheppard JD
    Expert Opin Pharmacother; 2018 Mar; 19(4):337-353. PubMed ID: 29430976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid.
    Kurucz I; Németh K; Mészáros S; Török K; Nagy Z; Zubovics Z; Horváth K; Bodor N
    Pharmazie; 2004 May; 59(5):412-6. PubMed ID: 15212312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.
    Bodor N; Drustrup J; Wu W
    Pharmazie; 2000 Mar; 55(3):206-9. PubMed ID: 10756542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs.
    Hochhaus G; Chen LS; Ratka A; Druzgala P; Howes J; Bodor N; Derendorf H
    J Pharm Sci; 1992 Dec; 81(12):1210-5. PubMed ID: 1491342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Major Esterase Involved in Hydrolysis of Soft Anticholinergic (2R3'R-SGM) Designed From Glycopyrrolate in Human and Rat Tissues.
    Samir A; Ohura K; Bodor N; Imai T
    J Pharm Sci; 2019 Aug; 108(8):2791-2797. PubMed ID: 30954525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: molecular identification and contribution to plasma metabolism.
    Ishizuka T; Fujimori I; Nishida A; Sakurai H; Yoshigae Y; Nakahara K; Kurihara A; Ikeda T; Izumi T
    Drug Metab Dispos; 2012 Feb; 40(2):374-80. PubMed ID: 22086979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.